About this Journal Submit a Manuscript Table of Contents
Interdisciplinary Perspectives on Infectious Diseases
Volume 2011 (2011), Article ID 146376, 6 pages
http://dx.doi.org/10.1155/2011/146376
Research Article

Influenza and Bacterial Pathogen Coinfections in the 20th Century

1Center for Public Health and Infectious Disease, Institutes of Biomedical Sciences, Fudan University, 138 Yi Xue Yuan Road, Shanghai 200032, China
2Key Laboratory of Medical Molecular Virology of MoH & MoE, Shanghai Medical College, Fudan University, Shanghai 200032, China
3International Vaccine Institute, Seoul 151-818, Republic of Korea
4Laboratory of Medical Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, China
5Department of Biostatistics, School of Public Health, Fudan University, Shanghai 200032, China

Received 6 October 2010; Revised 25 January 2011; Accepted 13 March 2011

Academic Editor: Melinda Pettigrew

Copyright © 2011 Xuan-Yi Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Wardlaw, E Johansson, and M. Hodge, Pneumonia: The Forgotten Killer of Children, UNICEF, New York, NY, USA, 2006.
  2. Pan-American-Health-Organization. PAHO strategic and operational plan for responding to pandemic influenza, 2005.
  3. World-Health-Organization. Seasonal, animal and pandemic influenza: an overview, 2008.
  4. T. Chonmaitree, K. Revai, J. J. Grady et al., “Viral upper respiratory tract infection and otitis media complication in young children,” Clinical Infectious Diseases, vol. 46, no. 6, pp. 815–823, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. W. Cripps, D. C. Otczyk, and J. M. Kyd, “Bacterial otitis media: a vaccine preventable disease?” Vaccine, vol. 23, no. 17-18, pp. 2304–2310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. F. Brundage, “Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness,” Lancet Infectious Diseases, vol. 6, no. 5, pp. 303–312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting,” Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Scopus
  8. P. Glasziou, I. Irwig, C. Bain, and G. Colditz, Frequency and Rate. Systematic Reviews Inhealth Care: A Practical Guide, Cambridge University Press, Cambridge, UK, 2nd edition, 2001.
  9. P. D. Austin and M. Elia, “A systematic review and meta-analysis of the risk of microbial contamination of aseptically prepared doses in different environments,” Journal of Pharmacy & Pharmaceutical Sciences, vol. 12, no. 2, pp. 233–242, 2009. View at Scopus
  10. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Scopus
  11. A. Whitehead, “Combining estimates of a treatment difference across trials,” in Meta-Analysis of Controlled Clinical Trials (Statistics in Practice), A. Whitehead, Ed., pp. 57–98, John Wiley & Sons, Chichester, UK, 2002.
  12. G. Palacios, M. Hornig, D. Cisterna et al., “Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza,” PloS One, vol. 4, no. 12, article e8540, 2009. View at Scopus
  13. J. R. Gill, Z. M. Sheng, S. F. Ely et al., “Pulmonary pathologic findings of fatal 2009 Pandemic influenza A/H1N1 viral infections,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 2, pp. 235–243, 2010. View at Scopus
  14. Centers for Disease Control and Prevention (CDC), “Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May-August 2009,” Morbidity and Mortality Weekly Report, vol. 58, no. 38, pp. 1071–1074, 2009.
  15. H. Goossens, “Antibiotic consumption and link to resistance,” Clinical Microbiology and Infection, vol. 15, supplement 3, pp. 12–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. D. E. Low, “Changing trends in antimicrobial-resistant pneumococci: it's not all bad news,” Clinical Infectious Diseases, vol. 41, supplement 4, pp. S228–S233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Madhi and K. P. Klugman, “A role for Streptococcus pneumoniae in virus-associated pneumonia,” Nature Medicine, vol. 10, no. 8, pp. 811–813, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Grabowska, L. Hogberg, P. Penttinen, S. Svensson, and K. Ekdahl, “Occurrence of invasive pneumococcal disease and number of excess cases due to influenza,” BMC Infectious Diseases, vol. 6, article 58, 2006. View at Publisher · View at Google Scholar · View at Scopus